Reliance Trust Co. of Delaware Takes $280,000 Position in Cigna Holding Co (CI)

Reliance Trust Co. of Delaware acquired a new position in shares of Cigna Holding Co (NYSE:CI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 1,474 shares of the health services provider’s stock, valued at approximately $280,000.

A number of other hedge funds also recently made changes to their positions in the business. Mascoma Wealth Management LLC raised its holdings in shares of Cigna by 8.1% during the fourth quarter. Mascoma Wealth Management LLC now owns 709 shares of the health services provider’s stock valued at $135,000 after acquiring an additional 53 shares in the last quarter. First Command Bank raised its holdings in shares of Cigna by 11.8% during the fourth quarter. First Command Bank now owns 636 shares of the health services provider’s stock valued at $121,000 after acquiring an additional 67 shares in the last quarter. First Command Financial Services Inc. raised its holdings in shares of Cigna by 11.8% during the fourth quarter. First Command Financial Services Inc. now owns 636 shares of the health services provider’s stock valued at $121,000 after acquiring an additional 67 shares in the last quarter. First Financial Corp IN raised its holdings in shares of Cigna by 10.1% during the fourth quarter. First Financial Corp IN now owns 786 shares of the health services provider’s stock valued at $150,000 after acquiring an additional 72 shares in the last quarter. Finally, Versant Capital Management Inc raised its holdings in shares of Cigna by 73.1% during the fourth quarter. Versant Capital Management Inc now owns 180 shares of the health services provider’s stock valued at $34,000 after acquiring an additional 76 shares in the last quarter. Hedge funds and other institutional investors own 93.44% of the company’s stock.

NYSE CI opened at $181.37 on Monday. Cigna Holding Co has a 12 month low of $163.02 and a 12 month high of $226.60. The firm has a market capitalization of $44.17 billion, a PE ratio of 12.75, a P/E/G ratio of 0.90 and a beta of 0.72. The company has a debt-to-equity ratio of 0.96, a quick ratio of 0.98 and a current ratio of 0.42.

Cigna (NYSE:CI) last released its earnings results on Friday, February 1st. The health services provider reported $2.46 EPS for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). Cigna had a return on equity of 16.64% and a net margin of 5.42%. The company had revenue of $13.75 billion during the quarter, compared to analysts’ expectations of $11.38 billion. During the same period in the prior year, the company posted $1.94 earnings per share. The company’s revenue was up 29.3% on a year-over-year basis. As a group, equities analysts anticipate that Cigna Holding Co will post 16.4 earnings per share for the current year.

In related news, Director William D. Zollars sold 201 shares of the stock in a transaction on Friday, December 14th. The stock was sold at an average price of $210.84, for a total transaction of $42,378.84. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 1.10% of the company’s stock.

Several equities research analysts recently weighed in on the company. Zacks Investment Research raised Cigna from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a research note on Friday, January 4th. Goldman Sachs Group reaffirmed a “buy” rating on shares of Cigna in a research note on Saturday, February 2nd. ValuEngine raised Cigna from a “sell” rating to a “hold” rating in a research note on Thursday, January 3rd. BMO Capital Markets upped their price target on Cigna from $220.00 to $230.00 and gave the stock a “hold” rating in a research note on Friday, November 2nd. Finally, Credit Suisse Group reaffirmed a “buy” rating and issued a $250.00 price target on shares of Cigna in a research note on Monday, January 7th. Four research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus price target of $229.09.

TRADEMARK VIOLATION WARNING: “Reliance Trust Co. of Delaware Takes $280,000 Position in Cigna Holding Co (CI)” was first reported by WKRB News and is the sole property of of WKRB News. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at https://www.wkrb13.com/2019/02/11/reliance-trust-co-of-delaware-takes-280000-position-in-cigna-holding-co-ci.html.

Cigna Profile

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Featured Article: Futures Contract

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply